2nd Oligonucleotides CMC & Analytical Development Summit 2023
Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression.
The 2nd Oligonucleotides CMC & Analytical Development Summit returns this August to Boston, uniting 70+ industry leaders. Across 3 days, senior leaders will leverage knowledge and share thought-leadership focused on improving analytical characterization, effectively preparing CMC data for IND filing and scaling up with long-term manufacturing in mind.
Here’s an insight into the comprehensive program and the actionable insights you could take away with you to fast track your pipelines:
- Improve analytical characterization to understand impurity profiles and ensure that quality standards are met
- Effectively prepare for CMC data submission for IND filing and navigate current regulatory environment
- Scale up your oligonucleotide with long-term manufacturability in mind – from cost considerations to commercial scale
- Capitalize on next generation of oligonucleotides for non-rare disease indications and future growth opportunities
Download Your Full Event Guide Here to see what’s on at the 2nd Oligonucleotides CMC & Analytical Development Summit. Including the expert speaker faculty, a full in-depth agenda and the incredible networking and collaboration opportunities on offer this year.
